[Featured Stock] Samsung Biologics Surpasses SK Hynix to Rank 2nd in Market Capitalization
[Asia Economy Reporter Song Hwajeong] Samsung Biologics has surpassed SK Hynix to become the second largest company by market capitalization on the KOSPI.
As of 9:46 AM on the 20th, Samsung Biologics recorded 810,000 KRW, up 0.12% (1,000 KRW) from the previous day. SK Hynix traded at 73,300 KRW, down 2.27% from the previous day.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
Accordingly, Samsung Biologics' market capitalization increased to 53.5937 trillion KRW, while SK Hynix's market capitalization decreased to 53.3626 trillion KRW, allowing Samsung Biologics to overtake SK Hynix and rise to second place. This is the first time in over four years that SK Hynix has dropped from the second position in market capitalization.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
